Evidence map›Paper›PMID 25305314›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.

Douglas C Macdonald, Alastair Hotblack, Saniath Akbar, Gary Britton, Mary K Collins, William C Rosenberg

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  2. Article
  3. A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  4. Review
  5. CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Douglas C MacdonaldDivision of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom;
Alastair HotblackDivision of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom;
Saniath AkbarDivision of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom;
Gary BrittonDivision of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom;
Mary K CollinsDivision of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom; National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertsfordshire EN6 3QG, United Kingdom; and mary.collins@ucl.ac.uk.
William C RosenbergDivision of Medicine, University College London, London WC1E 6BT, United Kingdom.
University College London · GBInstitute of Infection and Immunity · CANational Institute for Biological Standards and Control · GB

Funding

Department of HealthMedical Research Council G0501446Medical Research Council G0900374Medical Research Council G0900950Medical Research Council G9721629
6 · The paper itself

Abstract

Expression of the costimulatory receptor 4-1BB is induced by TCR recognition of Ag, whereas 4-1BB ligand (4-1BBL) is highly expressed on activated APC. 4-1BB signaling is particularly important for survival of activated and memory CD8(+) T cells. We wished to test whether coexpression of Ag and 4-1BBL by dendritic cells (DC) would be an effective vaccine strategy. Therefore, we constructed lentiviral vectors (LV) coexpressing 4-1BBL and influenza nucleoprotein (NP). Following s.c. immunization of mice, which targets DC, we found superior CD8(+) T cell responses against NP and protection from influenza when 4-1BBL was expressed. However, functionally superior CD8(+) T cell responses were obtained when two LV were coinjected: one expressing 4-1BBL and the other expressing NP. This surprising result suggested that 4-1BBL is more effective when expressed in trans, acting on adjacent DC. Therefore, we investigated the effect of LV expression of 4-1BBL in mouse DC cultures and observed induced maturation of bystander, untransduced cells. Maturation was blocked by anti-4-1BBL Ab, required cell-cell contact, and did not require the cytoplasmic signaling domain of 4-1BBL. Greater maturation of untransduced cells could be explained by LV expression of 4-1BBL, causing downregulation of 4-1BB. These data suggest that coexpression of 4-1BBL and Ag by vaccine vectors that target DC may not be an optimal strategy. However, 4-1BBL LV immunization activates significant numbers of bystander DC in the draining lymph nodes. Therefore, transactivation by 4-1BBL/4-1BB interaction following DC-DC contact may play a role in the immune response to infection or vaccination.

Indexed as

4-1BB LigandAnimalsAntigens, ViralBystander EffectCD8-Positive T-LymphocytesCell CommunicationDendritic CellsFemaleGenetic VectorsImmunizationInfluenza VaccinesLentivirusMiceMice, Inbred BALB COrthomyxoviridaeOrthomyxoviridae Infections4-1BB LigandAntigens, ViralInfluenza VaccinesTumor Necrosis Factor Receptor Superfamily, Member 9Viral Core Proteins

Identifiers

PMID25305314
PMCPMC4255227
OpenAlexW2119734578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.